Seeing Is Believing
TGTX is currently covered by 5 analysts with an average price target of $39.33. This is a potential upside of $10.56 (36.7%) from yesterday's end of day stock price of $28.77.
TG Therapeutics's activity chart (see below) currently has 87 price targets and 86 ratings on display. The stock rating distribution of TGTX is 82.61% BUY and 17.39% HOLD.
Analysts average stock forecasts to be materialized ratio is 74.58% with an average time for these price targets to be met of 318.58 days.
Highest price target for TGTX is $55, Lowest price target is $37, average price target is $42.25.
Most recent stock forecast was given by CORINNE JENKINS from GOLDMAN SACHS on 10-Jul-2025. First documented stock forecast 22-Jul-2014.
Currently out of the existing stock ratings of TGTX, 19 are a BUY (82.61%), 4 are a HOLD (17.39%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$37
$8.92 (31.77%)
$22
1 months 11 days ago
(10-Jul-2025)
6/9 (66.67%)
$-0.67 (-1.78%)
125
Buy
$55
$26.92 (95.87%)
$55
5 months 17 days ago
(04-Mar-2025)
14/20 (70%)
$19.38 (54.41%)
329
Buy
$43
$14.92 (53.13%)
$25
8 months 27 days ago
(25-Nov-2024)
8/8 (100%)
$8.39 (24.24%)
192
Buy
$34
$5.92 (21.08%)
$29
1 years 14 days ago
(07-Aug-2024)
14/14 (100%)
$14.01 (70.09%)
304
Buy
$19
2 years 1 months 26 days ago
(26-Jun-2023)
3/4 (75%)
$11.74 (161.71%)
176
What is TGTX (TG Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TGTX (TG Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TGTX (TG Therapeutics)?
Which analyst is the currently most bullish on TGTX (TG Therapeutics)?
Which analyst is the currently most reserved on TGTX (TG Therapeutics)?